One shot, better defence against cervical cancer

Women have a better shot at avoiding cervical cancer thanks to the single-dose human papillomavirus (HPV) vaccination, which has now been approved in South Africa.

The much-anticipated transition from the current two-vaccination strategy aligns with recent evidence-based World Health Organisation (WHO) recommendations.